Recombinant Fusion Constructs for Cancer Therapy

Development of a Commercial Pipeline in an Academic Setting
Michael G. Rosenblum, Ph.D
Immunopharmacology and
Targeted Therapy Laboratory
Department of Experimental Therapeutics
M.D. Anderson Cancer Center
Houston, Texas